Statistics
Total Visits
| Views | |
|---|---|
| Effectiveness and safety of daclatasvir/sofosbuvir with or without ribavirin in genotype 3 hepatitis C virus infected patients: results in real clinical practice | 265 |
Total Visits Per Month
| July 2024 | August 2024 | September 2024 | October 2024 | November 2024 | December 2024 | January 2025 | February 2025 | March 2025 | April 2025 | May 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Effectiveness and safety of daclatasvir/sofosbuvir with or without ribavirin in genotype 3 hepatitis C virus infected patients: results in real clinical practice | 7 | 3 | 7 | 3 | 9 | 6 | 17 | 8 | 10 | 6 | 0 |
File Visits
| Views | |
|---|---|
| Margusino_Effectiveness.pdf | 68 |
Top country views
| Views | |
|---|---|
| United States | 111 |
| Sweden | 30 |
| Ireland | 21 |
| Spain | 16 |
| China | 12 |
| Germany | 12 |
| Brazil | 7 |
| Ukraine | 6 |
| Cuba | 5 |
| France | 2 |
Top cities views
| Views | |
|---|---|
| Louisville | 24 |
| San Mateo | 18 |
| A Coruña | 8 |
| Mountain View | 7 |
| Stockholm | 7 |
| Ann Arbor | 6 |
| Dublin | 6 |
| Fremont | 6 |
| Ashburn | 5 |
| Costa Mesa | 5 |
